Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Small ; 17(23): e2006145, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33856096

RESUMEN

The organic-inorganic hybrid perovskite solar cells present a rapid improvement on power conversion efficiency from 3.8% to 25.5% in the past decades. Owing to the tuneable bandgaps, low-cost, and ease of fabrication, perovskites become ideal candidate materials for fabricating tandem solar cells, especially for efficient and high-voltage monolithic two-terminal devices. In this review, an overview of recent advances in various monolithic perovskite-based tandem solar cells with a focus on the key challenges is provided. Subsequently, the recombination layer materials, construction of wide-bandgap perovskite layer, stability of narrow-bandgap, and current matching principle in tandems are highlighted in order to optimize the output voltage and conversion efficiency of tandem solar cells. Finally, the recent progress is summarized with a focus on potential applications of tandem solar cells for energy conversion and storage, including hydrogen production by water splitting, CO2 reduction, supercapacitors, and rechargeable batteries, benefiting from the adjustable output voltage of tandem solar cells. It is hoped that this work can offer a feasible strategy to explore more possibilities for fabricating new two-terminal tandem solar cells with high voltage and high conversion efficiency for energy conversion and storage.

2.
Nat Commun ; 13(1): 64, 2022 Jan 10.
Artículo en Inglés | MEDLINE | ID: mdl-35013265

RESUMEN

Simultaneously harvesting, converting and storing solar energy in a single device represents an ideal technological approach for the next generation of power sources. Herein, we propose a device consisting of an integrated carbon-based perovskite solar cell module capable of harvesting solar energy (and converting it into electricity) and a rechargeable aqueous zinc metal cell. The electrochemical energy storage cell utilizes heterostructural Co2P-CoP-NiCoO2 nanometric arrays and zinc metal as the cathode and anode, respectively, and shows a capacity retention of approximately 78% after 25000 cycles at 32 A/g. In particular, the battery cathode and perovskite material of the solar cell are combined in a sandwich joint electrode unit. As a result, the device delivers a specific power of 54 kW/kg and specific energy of 366 Wh/kg at 32 A/g and 2 A/g, respectively. Moreover, benefiting from its narrow voltage range (1.40-1.90 V), the device demonstrates an efficiency of approximately 6%, which is stable for 200 photocharge and discharge cycles.

3.
Brain Res ; 1625: 189-97, 2015 Nov 02.
Artículo en Inglés | MEDLINE | ID: mdl-26363093

RESUMEN

The aim of this study was to investigate the effects of vasoactive intestinal peptide (VIP) on neurogenesis and neurological function after cerebral ischemia. Rats were intracerebroventricular administered with VIP after a 2h middle cerebral artery occlusion (MCAO) and sacrificed at 7, 14 and 28 days after MCAO. Functional outcome was studied with the modified neurological severity score. The infarct volume was evaluated via histology. Neurogenesis, angiogenesis and the protein expression of vascular endothelial growth factor (VEGF) were measured by immunohistochemistry and Western blotting analysis, respectively. The treatment with VIP significantly reduced the neurological severity score and the infarc volume, and increased the numbers of bromodeoxyuridine (BrdU) immunoreactive cells and doublecortin immunoreactive area in the subventricular zone (SVZ) at 7, 14 and 28 days after ischemia. The cerebral protein levels of VEGF and VEGF expression in the SVZ were also enhanced in VIP-treated rats at 7 days after stroke. VIP treatment obviously increased the number of BrdU positive endothelial cells in the SVZ and density of cerebral microvessels in the ischemic boundary at 28 days after ischemia. Our study suggests that in the ischemic rat brain VIP reduces brain damage and promotes neurogenesis by increasing VEGF. VIP-enhanced neurogenesis is associated with angiogenesis. These changes may contribute to improvement in functional outcome.


Asunto(s)
Infarto de la Arteria Cerebral Media/complicaciones , Enfermedades del Sistema Nervioso/tratamiento farmacológico , Enfermedades del Sistema Nervioso/etiología , Neurogénesis/efectos de los fármacos , Péptido Intestinal Vasoactivo/administración & dosificación , Animales , Antígenos CD34/metabolismo , Bromodesoxiuridina , Recuento de Células , Modelos Animales de Enfermedad , Proteínas de Dominio Doblecortina , Proteína Doblecortina , Células Endoteliales/efectos de los fármacos , Infarto de la Arteria Cerebral Media/tratamiento farmacológico , Masculino , Proteínas Asociadas a Microtúbulos/metabolismo , Neuropéptidos/metabolismo , Ratas , Ratas Sprague-Dawley , Factores de Tiempo , Factor A de Crecimiento Endotelial Vascular/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA